About
NeuroPace is a medical device company that specializes in the development of implantable neurostimulation devices for the treatment of neurological disorders such as epilepsy. The company was founded in 1997 and is headquartered in Mountain View, California.
NeuroPace’s flagship product is the RNS System, which is an implantable neurostimulation device that is designed to detect and respond to abnormal electrical activity in the brain. The RNS System consists of a small device that is implanted beneath the skull and connected to one or two leads that are placed on or within the surface of the brain.
The RNS System continuously monitors the brain for abnormal electrical activity, and when it detects such activity, it delivers small electrical pulses to the brain to suppress the abnormal activity. The device is programmed by a physician to deliver stimulation at specific times or in response to specific types of abnormal activity.
The RNS System has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of focal onset seizures in adults who have not responded to at least two anti-seizure medications. Clinical trials have shown that the RNS System can significantly reduce the frequency of seizures in patients with epilepsy.
NeuroPace Medical Devices
1 – Neuropace RNS System
The NeuroPace RNS System is an implantable medical device designed to help manage and treat epilepsy, specifically focal onset seizures. The device is implanted beneath the skull and connected to one or two leads that are placed on or within the surface of the brain.
The RNS System works by continuously monitoring the brain for abnormal electrical activity, which is a common characteristic of epilepsy. When the device detects this abnormal activity, it delivers small electrical pulses to the brain to suppress the activity and prevent seizures from occurring.
The RNS System is unique in that it is designed to be personalized to each individual patient’s needs. The device is programmed by a physician to deliver stimulation at specific times or in response to specific types of abnormal activity. This personalized approach allows for more targeted treatment and a higher likelihood of success.
